W STRATEGIES, LLC
W STRATEGIES, LLC is named as the registrant in 22 lobbying reports we hold for 2026-Q2, for 22 clients. 0 reports of 22 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| ABBOTT LABORATORIES | 2026-Q2: $50,000 in income | 1 |
| ABBVIE INC. | 2026-Q2: $50,000 in income | 1 |
| ALVEO TECHNOLOGIES | 2026-Q2: No amount stated | 1 |
| ASTRAZENECA PHARMACEUTICALS LP | 2026-Q2: $80,000 in income | 1 |
| BRISTOL-MYERS SQUIBB COMPANY | 2026-Q2: $50,000 in income | 1 |
| CALIFORNIA LIFE SCIENCES | 2026-Q2: $40,000 in income | 1 |
| DELFI DIAGNOSTICS | 2026-Q2: $30,000 in income | 1 |
| DYNE THERAPEUTICS, INC. | 2026-Q2: $40,000 in income | 1 |
| EXELIXIS, INC. | 2026-Q2: $60,000 in income | 1 |
| GILEAD SCIENCES, INC. | 2026-Q2: $60,000 in income | 1 |
| GLAXOSMITHKLINE | 2026-Q2: $40,000 in income | 1 |
| INCYTE CORPORATION | 2026-Q2: $60,000 in income | 1 |
| IPSEN BIOPHARMACEUTICALS, INC. | 2026-Q2: $20,000 in income | 1 |
| JUUL LABS INC | 2026-Q2: $60,000 in income | 1 |
| MEDTRONIC, INC. | 2026-Q2: $40,000 in income | 1 |
| MERCK & CO., INC. | 2026-Q2: $50,000 in income | 1 |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | 2026-Q2: $50,000 in income | 1 |
| PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICAL | 2026-Q2: $40,000 in income | 1 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2026-Q2: $60,000 in income | 1 |
| PHLOW CORP. | 2026-Q2: $50,000 in income | 1 |
| SANOFI U.S. SERVICES, INC. | 2026-Q2: $50,000 in income | 1 |
| UNITED SERVICES AUTOMOBILE ASSOCIATION (USAA) | 2026-Q2: $30,000 in income | 1 |
Lobbyists named in these reports
- DARREN WILLCOX · 22 reports · earlier government job reported
Bills named, and how the House and the Senate voted
4 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 946ORPHAN Cures Act | Introduced | No recorded vote in our record |
| H.R. 1406Lung Cancer Screening and Prevention Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 2300To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. | Introduced | No recorded vote in our record |
| H.R. 5376Impacts and Outcomes for Health Career Training Act | Introduced | No recorded vote in our record |
Issues named: Medicare/Medicaid (14), Health Issues (6), Medical/Disease Research/Clinical Labs (1), Pharmacy (1), Tobacco (1).
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| UNITED SERVICES AUTOMOBILE ASSOCIATION (USAA)Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| SANOFI U.S. SERVICES, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| PHLOW CORP.Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICALHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| OTSUKA AMERICA PHARMACEUTICAL, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| MERCK & CO., INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| MEDTRONIC, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| JUUL LABS INCTobacco | 2nd Quarter - Report | The report on LDA.gov | |
| IPSEN BIOPHARMACEUTICALS, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| INCYTE CORPORATIONMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| GLAXOSMITHKLINEMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| GILEAD SCIENCES, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| EXELIXIS, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| DYNE THERAPEUTICS, INC.Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| DELFI DIAGNOSTICSMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| CALIFORNIA LIFE SCIENCESMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| BRISTOL-MYERS SQUIBB COMPANYHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| ASTRAZENECA PHARMACEUTICALS LPMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| ALVEO TECHNOLOGIESMedical/Disease Research/Clinical Labs | 2nd Quarter - Report | The report on LDA.gov | |
| ABBVIE INC.Medicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| ABBOTT LABORATORIESHealth Issues | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.